Brain-derived neurotrophic factor (BDNF) improves molecular, cellular, and behavioral
measures of neural dysfunction in genetic models of Alzheimer's disease (;). However …

Levels of brain-derived neurotrophic factor (BDNF) are reduced in specific brain regions in
Alzheimer's disease (AD) and BDNF gene polymorphisms have been suggested to …

Brain derived neurotrophic factor (BDNF) promotes cholinergic neuron function and survival.
In Alzheimer's disease, BDNF mRNA and protein are decreased in basal forebrain …

The main focus of current drug development efforts for Alzheimer's disease is targeting the
amyloid-β (Aβ) brain plaques that are characteristic of the disease. However, there have …

Astrocytes, the most abundant type of glia in the brain, are considered to play a key role in
Alzheimer's disease (AD) pathologies. In a cell culture study, we have previously shown that …

Cytotoxicity of β-Amyloid (Aβ) is a major contributor to the pathogenesis of Alzheimer's
disease. Dexmedetomidine (Dex) has been revealed to have multiple neuroprotective …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular
accumulation of amyloid deposits. Brain-derived neurotrophic factor (BDNF) is a …

Beta-amyloid (Aβ) deposition is one important pathological hallmark in Alzheimer's disease
(AD). However, low levels of Aβ may modify critical endogenous protection systems before …

Objective To explore the effects of brain-derived neurotrophic factor (BDNF) pretreatment on
beta amyloid protein (Abeta) induced impairment of in vivo hippocampal long-term …

Brain-derived neurotrophic factor (BDNF) has been suggested to be involved in memory
processes. In the present study, the association between memory impairment at senescence …